Quick Answer
ENDRA Life Sciences Inc. reported R&D Expense of $1.85 million for fiscal year 2025.
ENDRA Life Sciences Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $1.85M | -42.0% |
| 2024 | $3.19M | -36.2% |
| 2023 | $5.00M | -23.7% |
| 2022 | $6.55M | +19.5% |
| 2021 | $5.48M | -7.4% |
| 2020 | $5.92M | -10.0% |
| 2019 | $6.57M | +39.2% |
| 2018 | $4.72M | +144.6% |
| 2017 | $1.93M | +289.8% |
| 2016 | $495.4K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $432.1K | -45.6% | -45.6% |
| September 30, 2024 | $794.4K | -51.3% | +10.9% |
| June 30, 2024 | $716.4K | -48.8% | -31.2% |
| March 31, 2024 | $1.04M | -25.1% | -36.2% |
| September 30, 2023 | $1.63M | -10.8% | +16.6% |
| June 30, 2023 | $1.40M | -24.2% | +0.6% |
| March 31, 2023 | $1.39M | +14.7% | -24.0% |
| September 30, 2022 | $1.83M | +56.0% | -0.9% |
- ENDRA Life Sciences Inc. showed a decrease of -42.0% in R&D Expense compared to the prior fiscal year.
- Over the 2016–2025 period, ENDRA Life Sciences Inc.’s r&d expense has grown by 273.5% (from $495.4 thousand to $1.85 million).
- The most recent figure is from ENDRA Life Sciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: